Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » BioDiem Update and EOFY Information
BioDiem Update and EOFY Information
July 4, 2024 •
Category
•
Author Name
24-07-04 BioDiem Update and EOFY information
Latest News
BioDiem Notice of General Meeting and Proxy Form
August 16, 2024
BioDiem Notice of General Meeting and Proxy Form
Read More
BioDiem Update and EOFY Information
July 4, 2024
24-07-04 BioDiem Update and EOFY information
Read More
